Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1994-12-21
|
pubmed:abstractText |
We have summarized some of the studies containing basic biological data suggesting potential therapeutic utility of the anti-proliferative activity of antiprogestins on uterine tissues. The non-competitive anti-oestrogenic effects of RU486 were examined using oestradiol-treated ovariectomized monkeys given RU486, progesterone or both. The oestradiol-induced luteinizing hormone surge of control animals was abrogated by progesterone and/or RU486. Secretory transformation by progesterone was inhibited by RU486 co-administration. RU486 alone (1 mg/kg) induced endometrial secretory transformation, but higher doses (5 mg/kg) induced inhibited proliferation and secretory activity. Thus, in the presence of progesterone, RU486 is antagonistic but, in its absence, RU486 exhibits endometrial progestational effects at low doses and an anti-proliferative (anti-oestrogenic) effect at higher doses. These data encourage continued evaluation of RU486 as a potential contraceptive agent acting at the pituitary and/or endometrial level. Our study also demonstrates that after physiological oestradiol replacement therapy, oestradiol receptor concentrations rise dramatically following antiprogestin treatment; this effect was dose-dependent.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chorionic Gonadotropin,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Mifepristone,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0268-1161
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-81
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:7962474-Animals,
pubmed-meshheading:7962474-Chorionic Gonadotropin,
pubmed-meshheading:7962474-Endometrium,
pubmed-meshheading:7962474-Estradiol,
pubmed-meshheading:7962474-Estrogen Antagonists,
pubmed-meshheading:7962474-Female,
pubmed-meshheading:7962474-Luteinizing Hormone,
pubmed-meshheading:7962474-Macaca fascicularis,
pubmed-meshheading:7962474-Mifepristone,
pubmed-meshheading:7962474-Ovariectomy,
pubmed-meshheading:7962474-Pituitary Gland, Anterior,
pubmed-meshheading:7962474-Primates,
pubmed-meshheading:7962474-Progesterone,
pubmed-meshheading:7962474-Receptors, Estrogen,
pubmed-meshheading:7962474-Up-Regulation
|
pubmed:year |
1994
|
pubmed:articleTitle |
Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models.
|
pubmed:affiliation |
Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk 23507.
|
pubmed:publicationType |
Journal Article,
Review
|